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Abstract
Background: The identification and differentiation of strains of Mycobacterium tuberculosis by DNA
fingerprinting has provided a better understanding of the epidemiology and tracing the transmission
of tuberculosis. We set out to determine if there was a relationship between the risk of belonging
to a group of tuberculosis patients with identical mycobacterial DNA fingerprint patterns and the
HIV sero-status of the individuals in a high TB incidence peri-urban setting of Kampala, Uganda.
Methods:  One hundred eighty three isolates of Mycobacterium tuberculosis from 80 HIV
seropositive and 103 HIV seronegative patients were fingerprinted by standard IS6110-RFLP. Using
the BioNumerics software, strains were considered to be clustered if at least one other patient had
an isolate with identical RFLP pattern.
Results: One hundred and eighteen different fingerprint patterns were obtained from the 183
isolates. There were 34 clusters containing 54% (99/183) of the patients (average cluster size of
2.9), and a majority (96.2%) of the strains possessed a high copy number (≥ 5 copies) of the IS6110
element. When strains with <5 bands were excluded from the analysis, 50.3% (92/183) were
clustered, and there was no difference in the level of diversity of DNA fingerprints observed in the
two sero-groups (adjusted odds ratio [aOR] 0.85, 95%CI 0.46–1.56, P = 0.615), patients aged <40
years (aOR 0.53, 95%CI 0.25–1.12, P = 0.100), and sex (aOR 1.12, 95%CI 0.60–2.06, P = 0.715).
Conclusion: The sample showed evidence of a high prevalence of recent transmission with a high
average cluster size, but infection with an isolate with a fingerprint found to be part of a cluster was
not associated with any demographic or clinical characteristics, including HIV status.
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Background
Tuberculosis (TB) remains a major health problem in
most of sub-Saharan Africa. In March 2008, the incidence
and mortality associated with tuberculosis in Uganda
were 355 cases and 84 deaths per 100,000 population per
year, respectively [1]. In this setting, a further danger lies
in the existence of TB/HIV co-infected individuals. Kam-
pala, the capital city of Uganda, has a population of over
two million people (National Housing and Census Sur-
vey, 2002) and carries 30% of the TB burden of the coun-
try (National TB and Leprosy Programme records).
Records from the National referral hospital, Mulago,
Kampala, show that 50% of TB patients are co-infected
with HIV. Rubaga, one of the five administrative divisions
surrounding the business capital of Kampala, has a resi-
dent catchment population of about 178,309 people and
an average population density of 4,000/sq km (projection
from the National Housing and Census Survey, 2002).
About 250–300 TB cases are diagnosed from the TB clinics
in the division quarterly (National TB and Leprosy Pro-
gramme records). Poor housing conditions and over-
crowding in most parishes of the division could facilitate
the transmission of TB in the communities.
Molecular genotyping tools have enhanced our under-
standing of the epidemiology of TB by providing insight
into the transmission dynamics, source and spread of M.
tuberculosis [2,3]. By helping to differentiate an ongoing
exogenous infection from reactivation, these tools also
help in evaluating TB control and treatment programmes
in a given setting [4]. One such genotyping tool, IS6110
Restriction Fragment Length Polymorphism (IS6110-
RFLP) analysis, exploits variability in both the number
and genomic position of the transposable element IS6110
to generate strain-specific patterns after PvuII restriction
digestion of genomic DNA [5]. Because it has been
observed that the molecular clock for IS6110-based RFLP
runs at a faster rate than that for the PCR-based Spoligo-
typing and Mycobacterial Interspersed Repetitive Unit
(MIRU) typing techniques [6], IS6110-RFLP is still
referred to as the gold standard molecular epidemiologi-
cal tool for TB in spite of its being labour intensive. In this
study, we have used standard IS6110-RFLP [5] to deter-
mine the rate of recently transmitted TB in Rubaga divi-
sion so as to understand the dynamics of transmission of
the disease in this community. The findings are related to
the HIV sero-status of the patients, socio-demographic
characteristics of the patients, as well as drug susceptibility
pattern of the isolates.
Methods
Setting and study population
Rubaga, one of the five administrative divisions of Kam-
pala city, covers an area of approximately 30 km2. It is
located in the western part of Kampala (Latitude: 0°18' 0
N, Longitude: 32°32' 60 E). The district is also home to
two missionary founded hospitals (Rubaga and Mengo)
and two other public health care clinics (Namungoona
health centre and JOY medical centre) that offer TB diag-
nostic and treatment services to patients under the super-
vision of the National TB and Leprosy Programme
(NTLP). A sample of 344 newly presenting TB patients
was enrolled at the four sites above from the resident pop-
ulation of Rubaga division between February and Septem-
ber 2006 so as to determine the species and strain
diversity of M. tuberculosis complex in this division [7,8].
Of 344 subjects enrolled, 92 (26.7%) were HIV seroposi-
tive, 176 (51.2%) seronegative, while 76 (22.1%) did not
consent to HIV testing and hence their status unknown. In
the current study, we have fingerprinted 183 isolates from
newly presenting patients with known HIV serostatus.
Twelve isolates from HIV seropositive patients did not
have adequate DNA for RFLP, so strains from only 80 HIV
seropositive were analyzed, while 103 strains from HIV-
seronegative individuals whose isolates had sufficient
growth on sub-culture were fingerprinted so as to study
the dynamics of TB transmission in HIV co-infected and
non-HIV co-infected patients in this setting by analysing
clustering by IS6110 RFLP. For the entire sample of 344
patients, 163 (47.4%) were from female patients while
181 (52.6%) were from male patients. In the current sub-
set, 81 (44.3%) of the isolates were from female patients
while 102 (55.7%) were from male patients. Five isolates
were resistant to isoniazid only while another five were
resistant to both isoniazid and rifampicin, hence multid-
rug resistant. All rifampicin resistant isolates were also
resistant to isoniazid.
Ethical considerations
Institutional permission to conduct the study was
obtained from the Faculty Research and Ethics Committee
of Makerere University Medical School (institutional eth-
ics board of the Medical School). Informed consent to
participate in the study as well as permission to use iso-
lates from samples provided were obtained from all
enrolled participants.
Demographic characteristics, drug susceptibility testing 
and HIV sero-status
These data were available from our previous analyzes of
the sample set [7,8].
IS6110-RFLP typing and clustering analysis
Heat killed isolates were shipped to the Swedish Institute
for Infectious Disease Control, Stockholm. Chromosomal
DNA extraction and IS6110-RFLP genotyping were per-
formed in accordance with a standard protocol described
previously [5], using an IS6110 right-side-specific probe.
BioNumerics (v 5.1) software (Applied Maths, Sint
Maarten Latem, Belgium) was used to analyze molecularBMC Infectious Diseases 2009, 9:12 http://www.biomedcentral.com/1471-2334/9/12
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typing results. IS6110-RFLP patterns were analyzed as fin-
gerprint types and the pair wise distance between patterns
was computed using unweighted pair-group method
using arithmetic averages (UPGMA) and the Jaccard index
[9]. Clusters were defined as at least two M. tuberculosis
strains with identical RFLP profiles isolated from different
patients. For strains with less than five bands, previous
spoligotyping data was used to analyze clustering [7].
Statistical analysis
Statistical associations between clustering, drug suscepti-
bility data, HIV sero-status and socio-demographic char-
acteristics were generated by Stata 8.0 using the Pearson's
chi-square test. Odds ratios were estimated at 95% confi-
dence intervals, and a P value of <0.05 was considered evi-
dence of a significant difference.
Results
Study population
A total of 183 isolates were fingerprinted, 81 from female
patients, 34 (41.9%) of whom were HIV seropositive; and
102 from males, 46 (45%) of whom were HIV seroposi-
tive. The number of patients in the 18 – 39 years age cate-
gory was 144, with 64 (44.4%) of them being HIV
seropositive, while the remaining 39 patients ranged
between 40 and 63 years of age with 16 (41%) of them
being HIV seropositive.
Analysis of IS6110 clusters
The RFLP pattern of the 183 isolates investigated gave 118
different IS6110 fingerprint patterns which included 34
genotype clusters consisting of 99 TB patients. The geno-
type clustering rate of the sample was 54.1% (99/183)
with a median genotype cluster size of 2.5 and an inter-
quartile range of 1. The largest genotype cluster had eight
strains, followed by two clusters with six strains (Figure 1).
The clustering rate among HIV seropositive patients was
52.5% (42/80) while that in the seronegative patients was
55.3% (57/103). The clustering rate within the gender was
54.3% (44/81) for females and 53.9% (55/102) for males
while that within the age categories was 56.9% (82/144)
for patients 18 to 39 years and 43.6% (17/39) for the 40
to 63 years category. Of the 183 samples analyzed, only
five (2.7%) isolates were resistant to both rifampicin and
isoniazid, defined as multi-drug resistant in this case and
only one multi-drug resistant case belonged to a cluster.
Bivariate analysis using odds ratio (OR) was used to com-
pare the socio-demographic characteristics and types of
patients, such as HIV sero-status, age of the patients, drug
susceptibility test results of the isolates as well as spoligo-
types lineages among the clustered genotypes. Having TB
resistant to at least one of the two drugs tested had an OR
greater than 1 but not statistically significant (P = 0.701),
while being male, below 40 years of age and HIV seropos-
itive each had a low OR, and were not statistically signifi-
cant (Table 1). Additionally, there was no significant
relationship between clustering and any of the three
major groups of spoligotype lineages tested: T2 (P = 0.45),
LAM (P = 0.41) and UGA (P = 0.47). Logistic regression
analysis of the four variables showed that being male and
having an isolate resistant to any of the two drugs tested
had an OR greater than 1, while being HIV seropositive
and below 40 years of age had an OR less than 1 (Table 2).
None of clinical and patient characteristics analyzed
showed a significant relationship with clustering in the
sample.
Analysis of IS6110 DNA fingerprints
The number of IS6110 copies for the 183 strains varied
from one to 20, the mean number was 13.3 and the most
frequent fingerprint pattern (n = 35) had 14 copies of
IS6110. The proportion of strains with less than five cop-
ies (low copy number of IS6110) was 3.8% (7/183),
89.1% (163/183) of the strains had eight to 17 copies,
while only 13 strains (7.1%) had 18 to 20 copies of
IS6110  (Figure 2). There was no relationship between
number of copies of IS6110 of the strains and the study
variables HIV sero-status (P = 0.922), age (P = 0.063) and
sex (P = 0.485) of the patients. Each of the seven strains
that possessed less than five copies belonged to one of
three clusters, 51.5% (84/163) of strains with eight to 17
copies were found in clusters, while eight of the 13 strains
with more than 17 copies were clustered. The IS6110 copy
number histogram (Figure 2) was skewed to the right with
96.2% of the strains being high copy number. Spoligo-
types of the seven strains with less than five copies (data
not shown) were clustered in three different patterns: two
strains with four copies each were of the T2 label (spoligo-
type international type, SIT, 52), three strains with a single
copy each were of the LAM11-ZWE label (SIT 59) while
another two strains with one copy each were EAI5 (SIT
126).
Comparison of the RFLP patterns between HIV-
seropositive and HIV seronegative TB patients
The level of diversity of the DNA fingerprints observed in
the HIV-seropositive TB patients was comparable to that
observed in the HIV-seronegative TB group. Sixty two
(77.5%) DNA fingerprint patterns were observed among
the 80 isolates obtained from HIV-seropositive TB
patients, and 74 patterns (71.8%) were found among 103
isolates derived from HIV-seronegative TB patients. The
risk of belonging to a group of patients with identical
RFLP patterns (or the risk of belonging to a chain of recent
TB transmission) was 52.5% (42/80) for the HIV-seropos-
itive group and 55.3% (57/103) for the HIV-seronegative
group (P = 0.6420). A dendrogram based on unweighted
pair-group method using arithmetic averages segregated
the isolates randomly with no indication of sub-structur-
ing according to the HIV sero-status of the patients (dataBMC Infectious Diseases 2009, 9:12 http://www.biomedcentral.com/1471-2334/9/12
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Diversity of IS6110-RFLP patterns in the clustered isolates with corresponding demographic data (n = 99) Figure 1
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not shown). The number of IS6110 copies ranged from
one to 18 for the HIV-Seropositive group and from one to
20 for the HIV-seronegative group. Analysis of the histo-
gram (Figure 2) shows that the frequency of occurrence of
IS6110 bands for the isolates appeared to be rather similar
between the two groups being compared. For example,
the most prevalent pattern observed had a peak of 14 cop-
ies of IS6110 (n = 35), with 17 and 18 of the strains being
from HIV seropositive and HIV seronegative patients
respectively.
Discussion
The identification and differentiation of strains of M.
tuberculosis by IS6110-RFLP has provided a better under-
standing of the epidemiology and tracing the transmis-
sion of TB in developed countries. However, not much is
known in most developing countries where the disease
burden is highest. Previous studies done in some sub-
Saharan African countries have reported contrasting
results in regard to risk factors for the transmission of TB
[10-13]. In this study, we have analyzed the transmission
dynamics of TB in HIV seropositive and seronegative TB
patients, and within age groups so as to study the associa-
tion between these variables and ability to transmit TB in
a high disease burden peri-urban setting of Uganda.
Analysis of clusters in our sample showed 118 patterns
from the 183 strains fingerprinted. A large proportion
(99/183 or 54.1%) of our sample belonged to clusters,
suggesting a high prevalence of transmission. Even after
removal of clusters containing strains with less than five
copies of IS6110, our result differs from that shown in a
previous finger print analysis of 73 isolates from different
villages of Kampala [14] in which it was shown that only
six (8.2%) of the isolates typed clustered, suggesting that
multiple strains were transmitted in the community. It is
generally known that high disease burden settings are
characterized by a limited variety of M. tuberculosis strains
and a high proportion of isolates occurring in clusters
[15,16]. The difference in the two results above, moreover
from the same setting, could be due to the sampling strat-
egy: while we sampled resident patients at TB clinics in a
single division of Kampala, the previous study was based
at the National referral hospital, with patients originating
from villages of different divisions of the city. It is known
that measured clustering depends on such factors as com-
pleteness of sampling, immigration and time period [17].
While our previous study sampled 2,639 suspects from a
resident population of a division of Kampala, only 344
(13%) turned out smear positive and were therefore
recruited [8]. Since smear microscopy has a detection
Table 1: Association of variables with M. tuberculosis genotype clustering by IS6110-RFLP analysis (n = 183)
Genotype clustering
Demographic characteristics No Yes Unadjusted OR 95%CI P value
Sex
Female 37 44 Reference
Male 47 55 0.98 0.55–1.77 0.957, NS
Age, years
>40 22 17 Reference
<40 62 82 0.58 0.28–1.19 0.140, NS
HIV sero-status
Negative 46 57 Reference
Positive 38 42 0.89 0.49–1.60 0.702, NS
Drug susceptibility*
Sensitive 80 93 Reference
Any resistance 4 6 1.29 0.35–4.73 0.701, NS
OR = odds ratio; CI = confidence interval; NS = not significant; * = susceptibility to isoniazid and rifampicin only.BMC Infectious Diseases 2009, 9:12 http://www.biomedcentral.com/1471-2334/9/12
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limit below 50% in our setting (National TB Reference
Laboratory records, Uganda), some TB cases could have
been missed and therefore the true proportion of cluster-
ing in our study may have been underestimated. Addi-
tionally, in an attempt to compare an almost equal
sample of HIV positive and HIV negative TB patients, only
183 of the 344 isolates (53.2%) were analyzed for cluster-
ing in the present study, a further limitation to estimating
the actual clustering rate in the community studied.
Previous studies have shown varying clustering propor-
tions dependent on length of the sampling period in set-
tings with similar disease burdens. In South Africa for
example, a one year study showed a proportion of cluster-
ing of 50% among gold miners [18]. This result is close to
that obtained in the present study in which 54.1% of the
isolates obtained over a 9 months period clustered. These
results, however, differ from those obtained in longitudi-
nal studies over years as they allow a greater number of
exposed persons to progress to active TB. Cases in point
are clustering rates of 72% in a six year study in Cape
Town, South Africa, [13] and 73.6% in an area with a high
HIV prevalence in Northern Malawi [11]. In a more recent
analysis, it has been shown that both epidemiologic and
strain related factors may contribute to cluster size [19]. It
was further shown that spoligotype 59 in a Malawi popu-
lation in all groups of patients, was clustered and unique,
and was associated with a wide diversity of RFLP patterns.
This is in agreement with our previous observation of pre-
dominance of RD 724 deleted – T2 spoligotypes of M.
tuberculosis in this locale [8].
Our study shows that the average cluster size of 2.9 in our
sample was twice that observed in another high burden
setting, Tanzania, where Yang and colleagues [20] showed
an average cluster size of 1.33. This difference in average
cluster size between ours and the Tanzania study may be
due to the fact that they sampled the city of Dar es Salaam,
with patients originating from other parts of Tanzania as
well, while in our study only the resident population was
considered and being a non-resident of Rubaga division
was an exclusion criterion. The high average cluster size in
our study however, is comparable with the 3.7 observed in
isolates from Addis Ababa residents in Ethiopia [10].
Only 10 of the 183 isolates were resistant to isoniazid,
including five that were resistant to rifampicin as well,
hence multidrug resistant. All the isolates from the sample
analyzed were from newly presenting TB patients; hence
the resistance of these isolates was considered primary
drug resistance. There was no significant difference in the
frequency of drug resistance between patients with clus-
Table 2: Logistic regression analysis of the association of variables with genotype clustering by IS6110-RFLP for strains with >5 copies 
of IS6110 (n = 176)
Demographic characteristics †aOR 95%CI P value
Sex
Female Reference
Male 1.12 0.60–2.06 0.715, NS
Age, years
≥ 40 Reference
≤ 40 0.53 0.25–1.12 0.100, NS
HIV sero-status
Negative Reference
Positive 0.85 0.46–1.56 0.615, NS
Drug susceptibility*
Sensitive Reference
Any resistance 1.44 0.38–5.38 0.586, NS
†Logistic regression adjusted for four variables in this table; aOR = adjusted odds ratio; CI = confidence interval; NS = not significant; * = 
susceptibility to isoniazid and rifampicin only.BMC Infectious Diseases 2009, 9:12 http://www.biomedcentral.com/1471-2334/9/12
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tered genotypes and those with unique genotypes (Table
2). Although the number of patients with strains resistant
to any drug in our sample was small, this result contrasted
with findings in Ethiopia in which 62.5% of 17 isolates
resistant to any drug were found within clusters [10].
The relationship between clustering and sex as well as
between clustering and age groups was also analyzed.
Generally, as was observed in a study in Botswana [21],
there was no statistical link between the risk of a patient
belonging to a cluster and any of the demographic charac-
teristics above (Table 2). These results further differ from
observations in Ethiopia [10] in which there was a trend
toward increased clustering of isolates from tuberculous
women residing in Addis Ababa. In northern Malawi, on
the other hand, there was a weak association between
clustering and sex, with clustering more common in
women ≥ 45 years of age [11]; while in South Africa, clus-
tering was not associated with sex but clustered cases
seemed to decrease with age, though not significantly
[13].
The IS6110 copy number of the isolates ranged from 1 to
20, which is similar to that in the Tanzania study [20] and
close to the range of 1 to 17 copies in the earlier study in
Kampala [14]. These results are also comparable with that
from Tunisia [22] where 75% of the isolates were high
copy number. However, there were significant differences
in the distribution of the copy number between our
strains and those in the Tanzania sample in that the pro-
portion of strains with less than six copies (considered
low copy number strains) in this study was 3.8% (Figure
2) and 4.1% (3/73) in the previous Kampala study [14],
while that in the Tanzania study was 26.1% (35/134). In
fact, the isolates carrying only a single copy of the IS6110
element in the Tanzania study was 8%, while only 2.7%
(5/183) of our strain collection and 2.7% (2/73) of the
previous Kampala study harbored a single copy of the ele-
ment. More interestingly, the Tanzania study found a clear
correlation between the occurrence of low copy number
of IS6110 and classification of the strains into the Asian
subgroup, while in our previous analysis of the full set of
344 samples by spoligotyping, we observed that 70%
(241/344) of our strain collection was of the T2 type
(Euro-American) while only CAS1-Kili (3.5%) and CAS1-
Delhi (2.6%) belonged to the Asian subgroup [7]. These
results further confirm observations that statistically sig-
nificant association of a clone to the prevalence of disease
in a community may reflect increased adaptation and fit-
ness of the strain type [23].
A majority (96.2%) of the strains in our sample and
95.9% of strains from the earlier Kampala study were high
copy number, with histograms of the distribution of
Analysis of copy number in IS6110-based DNA fingerprints of M. tuberculosis for the 183 strains Figure 2
Analysis of copy number in IS6110-based DNA fingerprints of M. tuberculosis for the 183 strains.BMC Infectious Diseases 2009, 9:12 http://www.biomedcentral.com/1471-2334/9/12
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IS6110 copies from both studies skewed to the right. In
northern Malawi and Botswana, on the other hand, histo-
grams showed a normal distribution for the IS6110 cop-
ies. It has been observed elsewhere that high IS6110 copy
strains can be epidemiologically resolved using a smaller
set of loci on MIRU-VNTR genotyping panel [24]. Our
data therefore suggests that it is possible to quickly estab-
lish epidemiological links for this group of strains using a
less laborious and high throughput PCR-based technique.
A comparison of the RFLP patterns of HIV-related and
non-HIV-related isolates showed no significant differ-
ences between the categories. The risk of belonging to a
group of patients with identical RFLP patterns was not sig-
nificantly different between the two categories (Table 2).
A number of studies about clustering in TB/HIV co-
infected patients have yielded contrasting results. In one
of these, in a high disease incidence region of Spain, a
study of 305 TB patients with known HIV serostatus
showed that strains isolated from HIV-positive patients
were not associated with clustering [25] a result similar to
observations by Yang et al [20] in Tanzania. More studies
in sub-Saharan Africa have pointed to absence of associa-
tion between HIV serostatus and clustering. A study in a
high HIV prevalence district of northern Malawi did not
find any association between clustering in TB patients and
HIV serostatus [19]. A similar result was obtained in a
population-based prospective study of pulmonary TB
patients in Botswana, in which HIV positivity was not
associated with clustering even after stratification by site
[21]. In Ethiopia, on the other hand, HIV positive serosta-
tus was significantly associated with clustering of isolates
for patients of both sexes [10], a result similar to that
obtained in Lima, Peru, using fluorescent Amplification
Fragment Length Polymorphism (fAFLP), in which the
highest levels of relatedness were found among isolates
from the same disease group, with the isolates grouping
into two distinct clusters [23]. It may argued that observa-
tion of clonal groupings among the AIDS-associated iso-
lates in Peru may have been due to the effect of
hospitalization of the patients since all the 25 isolates
from HIV-1-negative individuals were found to be rela-
tively heterogeneous and nonclonal.
Since a majority (144/183) of the patients in our sample
was aged between 18 – 39 years inclusive, the absence of
association between HIV serostatus and M. tuberculosis
clustering in this study may be due to a very high propor-
tion of disease attributable to recent transmission in HIV
negative patients in the younger category, as has been pos-
tulated elsewhere [11].
Conclusion
The sample analyzed showed evidence of on-going trans-
mission of TB in this setting. However, there was no statis-
tical relationship between the risk of a patient belonging
to a transmission chain and his or her HIV status, gender,
age or drug susceptibility pattern of the strains. A major
shortcoming of the study however, is that we included
only a subset of patients diagnosed over a nine months
period, and this limited the sensitivity for detecting clus-
ters, the consequence being a low power to detect
observed differences as statistically significant.
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